Zobrazeno 1 - 3
of 3
pro vyhledávání: '"P. Badrinadh Gupta"'
Publikováno v:
Synthetic Communications. 42:3200-3210
Deferasirox is an orally active iron chelating agent, and during process development for deferasirox, we observed six related substances (impurities), namely deferasirox methyl ester, deferasirox salicylyl derivative, deferasirox ethyl ester, deferas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::364f4216548d14995577163468ff951a
https://doi.org/10.1080/00397911.2011.580068
https://doi.org/10.1080/00397911.2011.580068
Autor:
Aminul Islam, N. Murali, V. Kumar, Srikanth Guntupalli, D. Satheesh, Uttam Kumar Ray, P. Badrinadh Gupta
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 88
During the synthesis of ezetimibe, two process related impurities were detected were HPLC analysis at levels ranging from 0.05 to 0.8%. These two impurities were isolated by column chromatography and co-injected with ezetimibe sample to confirm the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf8b68abe78ccf83584472f9b255d279
https://pubmed.ncbi.nlm.nih.gov/24176742
https://pubmed.ncbi.nlm.nih.gov/24176742
Autor:
Hu, Yiping1 (AUTHOR), Jiao, Shulin1 (AUTHOR), Wang, Yanyan1 (AUTHOR), Chen, Ruicheng1 (AUTHOR), Li, Gen1 (AUTHOR), Zou, Zhihong1 (AUTHOR) 101006373@seu.edu.cn
Publikováno v:
ChemistrySelect. 12/6/2021, Vol. 6 Issue 45, p12914-12920. 7p.